Status:

COMPLETED

Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates

Lead Sponsor:

Institut de Recherche en Sciences de la Sante, Burkina Faso

Conditions:

Malaria

Malaria Prophylaxis

Eligibility:

All Genders

Phase:

PHASE4

Brief Summary

Malaria represents a major public health concern in sub-Sahara Africa. Seasonal malaria chemoprevention (SMC) is one of the largest preventive measures. It consists to administer Amodiaquine+Sulfadoxi...

Detailed Description

Malaria represents a major public health concern in sub-Sahara Africa. According to the World Health Organization (WHO) nearly half of the world's population is exposed to malaria infection causing 40...

Eligibility Criteria

Inclusion

  • Single household (not sharing the same concession with other households) with children under SMC coverage (aged 3-59 months) with at least one child under 35 months of age,
  • Household members residing within the HDSS catchment area,
  • Willingness of roommates to be screened and treated,
  • Ability to complete the study follow-up period,
  • Written consent obtained from parents/guardian
  • Written consent/assent obtained from roommates

Exclusion

  • Household with children under SMC coverage who did not receive the SMC (Amodiaquine-Sulfadoxine-Pyrimethamine) or sharing the same concession with other households
  • Household with children under SMC coverage but at least one of his/her roommates refuse to be screened and treated (these children will still receive the SMC treatment as part of their routine malaria prevention policy)
  • Severely ill individual at the time of enrolment including severe malaria,
  • Known allergy to AQSP for children and DHAPPQ for roommates
  • Planned travel or inability to complete the study follow-up,
  • Participation to malaria vaccine trial
  • Unwillingness to participate to the study.

Key Trial Info

Start Date :

July 7 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2023

Estimated Enrollment :

526 Patients enrolled

Trial Details

Trial ID

NCT04816461

Start Date

July 7 2021

End Date

June 30 2023

Last Update

January 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut de Recherche en Sciences de la Santé/ Clinical Research Unit of Nanoro

Nanoro, Boulkiemdé, Burkina Faso, 18 campus urcn